Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) fell 8.8% during trading on Tuesday . The company traded as low as C$0.16 and last traded at C$0.16. 172,268 shares traded hands during trading, a decline of 41% from the average session volume of 289,881 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Down 8.8 %
The firm has a 50-day moving average price of C$0.10 and a two-hundred day moving average price of C$0.13. The company has a market capitalization of C$25.14 million, a P/E ratio of -4.79 and a beta of 0.39. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Are Penny Stocks a Good Fit for Your Portfolio?
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Investing In Preferred Stock vs. Common Stock
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
